Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...
HC Wainwright raised their FY2028 earnings per share (EPS) estimates for Denali Therapeutics in a report issued on Tuesday, January 7th. HC Wainwright analyst A. Fein now expects that the company will ...
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Rapport Therapeutics, Inc. (RAPP – Research Report) yesterday. The company’s ...
GlobalData on MSN17h
IMG Biosciences enacts massive lay-offs after Phase I trial failureFollowing the negative Phase I trial outcome for its autoimmune disease treatment, the company is cutting 73% of jobs.
After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...
Imunon, Inc. (NASDAQ:IMNN – Get Free Report) dropped 7.2% during trading on Thursday . The stock traded as low as $0.89 and last traded at $0.91. Approximately 201,898 shares changed hands during ...
21h
NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...
Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback